National and Kapodistrian University of Athens Medical School, Department of Pharmacology, Athens, Greece, Athens 11527, Greece.
GAIA Research Center, Bioanalytical Department, The Goulandris Natural History Museum, Kifissia14562, Greece.
Biomol Concepts. 2020 Dec 23;11(1):201-208. doi: 10.1515/bmc-2020-0018.
Natural products have served humanity as a valuable source for the discovery and development of therapeutic agents. In addition, these phytochemicals can function as lead compounds for the development of synthetic analogs aimed at treating human diseases. In our aging society, Alzheimer's disease (AD) is the most common cause of dementia, which is characterized by a significant and progressive loss of memory and other cognitive functions. As society demographics change, the predominance of AD and other age-related dementias is increasing, with concurrent financial and societal costs.AD represents one of the most remarkable scientific challenges for drug discovery as the search for effective disease-modifying agents has been unsuccessful. Medicinal plants have been used for their "anti-aging" properties, and cognitive enhancing properties. In the past decades, natural products have been studied for their anti-AD properties, and their potential for developing therapeutic agents against several molecular targets has been evaluated. This insight evaluates the prospects of medicinal plants for providing disease-modifying, as well as disease-preventing, agents for AD.
天然产物一直是人类发现和开发治疗药物的宝贵资源。此外,这些植物化学物质可以作为开发针对人类疾病的合成类似物的先导化合物。在我们这个老龄化的社会中,阿尔茨海默病(AD)是痴呆症最常见的原因,其特征是记忆和其他认知功能的显著和进行性丧失。随着社会人口结构的变化,AD 和其他与年龄相关的痴呆症的发病率正在上升,同时带来了经济和社会成本。AD 是药物发现最具挑战性的科学问题之一,因为寻找有效的疾病修饰剂的努力一直没有成功。药用植物因其“抗衰老”特性和认知增强特性而被使用。在过去的几十年中,人们一直在研究天然产物的抗 AD 特性,并评估了它们针对几种分子靶标开发治疗药物的潜力。这种观点评估了药用植物在提供疾病修饰以及预防 AD 疾病的药物方面的前景。